Obesity Drugs Should Be Covered Under Part D, Drug Firms Urge CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
“Obesity” is a medical condition that differs from the excluded Part D category of weight loss products, PhRMA says in comments on recently proposed Medicare rule.